Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2026
Protective Effects of Topical and Systemic Ferulic Acid Treatment on Myringosclerosis in a Rat Model.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sahin Batuhan, Celik Hatice, Kaytez Selda Kargın, Yumusak Nihat
Аннотация
PURPOSE: Myringosclerosis is a frequent sequela following tympanic membrane injury, with oxidative stress playing a key role in its pathogenesis. Ferulic acid (FA), a natural antioxidant, has demonstrated protective effects in various experimental models. This study aimed to evaluate the effects of topical and systemic FA administration on myringosclerosis formation in a rat model.
METHODS: Thirty female Wistar albino rats were divided into 3 groups: control, topical FA, and systemic FA. Myringotomy was performed on the right ear of the control group and on both ears of the FA groups. FA was administered topically (0.1 mL to the external ear canal once daily) or intraperitoneally (150 mg/kg/d intraperitoneally) for 4 consecutive days. Otomicroscopic examinations and histopathologic evaluations (tympanic membrane thickness, inflammatory cell count, and histopathologic scoring) were performed on postoperative day 15. Data were analyzed using nonparametric tests with Bonferroni correction.
RESULTS: Both topical and systemic FA significantly reduced otomicroscopy and histopathologic scores, tympanic membrane thickness, and inflammatory cell infiltration compared with controls ( P <0.001). Topical FA administration resulted in significantly thinner tympanic membranes than systemic administration ( P <0.001), with no other significant differences between FA groups.
CONCLUSIONS: FA effectively attenuates myringosclerosis formation in this rat model, with topical administration showing superior effects on tympanic membrane thickness. These findings suggest potential clinical applications of FA in preventing postoperative myringosclerosis, warranting further preclinical and clinical research.
METHODS: Thirty female Wistar albino rats were divided into 3 groups: control, topical FA, and systemic FA. Myringotomy was performed on the right ear of the control group and on both ears of the FA groups. FA was administered topically (0.1 mL to the external ear canal once daily) or intraperitoneally (150 mg/kg/d intraperitoneally) for 4 consecutive days. Otomicroscopic examinations and histopathologic evaluations (tympanic membrane thickness, inflammatory cell count, and histopathologic scoring) were performed on postoperative day 15. Data were analyzed using nonparametric tests with Bonferroni correction.
RESULTS: Both topical and systemic FA significantly reduced otomicroscopy and histopathologic scores, tympanic membrane thickness, and inflammatory cell infiltration compared with controls ( P <0.001). Topical FA administration resulted in significantly thinner tympanic membranes than systemic administration ( P <0.001), with no other significant differences between FA groups.
CONCLUSIONS: FA effectively attenuates myringosclerosis formation in this rat model, with topical administration showing superior effects on tympanic membrane thickness. These findings suggest potential clinical applications of FA in preventing postoperative myringosclerosis, warranting further preclinical and clinical research.